期刊文献+

磷霉素与氨基糖苷类药物联用对体外铜绿假单胞菌生物被膜中活菌数的测定 被引量:4

The Effect of the Combination of Fosfomycin and Aminoglycosides on the Viable Counts of Pseudomonas Aeruginosa Biofilm in Vitro
下载PDF
导出
摘要 目的通过研究磷霉素与氨基糖苷类药物(阿米卡星、异帕米星)联合应用对铜绿假单胞菌生物被膜的体外联合效应,探讨磷霉素对氨基糖苷类药物在抑制铜绿假单胞菌生物被膜形成方面的作用。方法采用改良的组织培养平板法建立铜绿假单胞菌生物被膜模型,应用活菌计数法观察经不同剂量的两类药物单用与联合作用处理后的铜绿假单胞菌生物被膜的活菌数量,对其进行比较与分析。结果联药组处理的生物被膜内活菌数较单药组显著下降,表明磷霉素与阿米卡星/异帕米星二者联合应用后,生物被膜的形成被抑制,存活细菌数量显著减少。结论研究发现磷霉素与氨基糖苷类药物联用对铜绿假单胞菌生物被膜形成的抑制具有显著增效作用。 Objective To study the combination effect of fosfomycin and arninoglycosides on the for mation of biofilm of Pseudomonas aeruginosa(PAO1 ) in vitro. Methods The modified plate culture method was used to establish biofilm model in vitro with which the morphology of PAO1 biofilms were observed by the viable counts after treated with different dosages of fosfomycin and aminoglycosides. Results MTT method showed that the viable counts of bacteria of combination gruops were significantly lower than the non-combination groups (P〈0.05). Conclusions There were obvious differences between combination fosfomycin and aminoglycosides groups and non-combination groups in the formation of PAO1 biofilm. Synergistic action of fosfomycin to aminoglycosides is verified.
作者 范燕 王睿
出处 《中国药物警戒》 2010年第1期1-4,共4页 Chinese Journal of Pharmacovigilance
基金 国家自然科学基金资助项目(30070720)
关键词 磷霉素 氨基糖苷类药物 细菌生物被膜(BBF) 铜绿假单胞菌野生菌株(PAO1) fosfomycin aminoglycosides bacterial biofilm(BBF) Pseudomonas aeruginosa(PAO1 )
  • 相关文献

参考文献9

  • 1Rebecca L, Delegge, Mark H, et al. Percutaneous endoscopic gastrostomy evaluation of device materials: are we "Failsafe"[J]. Nutr Clin Pract,2005, 20: 613-617.
  • 2徐志豪,刘富光,王选锭,原双晋,李丽红.红霉素、磷霉素对铜绿假单胞菌生物被膜体外作用的研究[J].中华结核和呼吸杂志,2001,24(6):342-344. 被引量:42
  • 3方向群,刘又宁,陈迁,王睿.阿奇霉素对生物被膜的抑制及对氟罗沙星的增效作用[J].中华结核和呼吸杂志,1998,21(9):538-540. 被引量:67
  • 4范燕,王睿,安毛毛,蔡芸,梁蓓蓓,刘茹,柴栋,裴斐.磷霉素与氨基糖苷类药物联用对体外铜绿假单胞菌生物被膜形态学的影响[J].中国药物应用与监测,2007,4(5):18-20. 被引量:10
  • 5Costerton W,Veeh R, Shirtliff M, et al. The application of biofilm science to the study and control of chronic bacterial infections[J]. J Clin Invest, 2003,112(10): 1466-1477.
  • 6Hamilton J A. Nondisposable materials, chronic inflammation, and adjuvant action[J]. J Leukoc Biol,2003,73(6): 702-712.
  • 7Ssariello C,Berlutti F, Selan L, et al. A rapid staining proce- dure to demonstrateglycocalyx production and bacterial biofilms [J]. Microbiologica, 1994, 17:225-228.
  • 8Barbara A.David C.Laux, et al. Radioc- hemical method for evaluating the effect of antibiotics on Escherichia coli biofilm [J]. Antimicrobial Agents and Chemotherapy, 1988,5: 770.
  • 9Ashby M J, Neele J E, Knott S J, et al. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coil [J]. J Antimicrobial Chemotherapy, 1994,33:443.

二级参考文献16

  • 1佟金平,王镇山,薛欣,顾俊明.磷霉素与14种抗菌药物分别联用的体外抗菌活性研究[J].中国抗生素杂志,2005,30(4):233-237. 被引量:26
  • 2小野宪昭,门田晃一,津川昌也,他.Robbins deviceを用いた大肠菌バイオフイルムの解析[J].日本化学疗法学会杂志,1995,(43):987.
  • 3[2]Costerton JW,Cheung W,Geesey GG.Bacterial biofilm in nature and disease[J].Ann Rev Microbiol,1987,41:435.
  • 4[4]Monden K,Ando E,Iida M,et al.Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm[J].J Infect Chemother,2002,8(3):218.
  • 5[6]Passariello C,Berlutti F,Selan L,et al.A rapid staining prodedure to demonstrate glycocalyx production and bacterial biofilms[J].Microbiology,1994,17:225.
  • 6[7]Rebecca L,Delegge,Mark H,et al.Percutaneous endoscopic gastrostomy evaluation of device materials:are we "Failsafe"?[J].Nutr Clin Pract,2005,20:613.
  • 7[8]Hamilton JA.Nondisposable materials,chronic inflammation,and adjuvant action[J].J Leukoc Biol,2003,73(6):702.
  • 8[9]Costerton W,Veeh R,Shirtliff M,et al.The application of biofilm science to the study and control of chronic bacterial infections[J].J Clin Invest,2003,112(10):1466.
  • 9陈迁,中国抗生素杂志,1997年,22卷,435页
  • 10娄永新,实用临床细菌学检验与进展,1993年,247页

共引文献110

同被引文献36

  • 1黄祥,王健民,李勇.磷霉素的药动学药效学特性与临床应用[J].中国医院药学杂志,2005,25(2):156-158. 被引量:61
  • 2赵风景,黄金华.烧伤感染的综合防治[J].医学综述,2006,12(3):147-149. 被引量:17
  • 3范燕,裴斐,梁蓓蓓,童卫杭,刘建行,李鑫,董涛,蔡芸,王睿.磷霉素与五种氨基糖苷类抗菌药物对20株铜绿假单胞菌的联合药敏研究[J].中国药物应用与监测,2007,4(1):47-49. 被引量:7
  • 4方向群,刘又宁.亚胺培南联合阿奇霉素治疗铜绿假单胞菌生物被膜感染的实验研究[J].中华医院感染学杂志,2007,17(3):254-257. 被引量:34
  • 5陈新谦 金有豫.新编药物学[M].北京:人民卫生出版社,1998.113-114.
  • 6Costerton W, Veeh R, Shirtliff M, et al. The application of biofilm science to the study and control of chronic bacterial infections [J]. J Clin Invest, 2003, 112(10): 1466-1477.
  • 7Morin J P, Bendirdjian J P, Pillastre A, et al. Interference of fosfomycin with lysosomal membrane integrity of rat kidney cells[J]. Drugs Exptl Clin Res, 1978,4: 63.
  • 8Hamilton J A. Nondisposable materials, chronic inflammation, and adjuvant action[J]. J Leukoc Biol, 2003,73(6): 702-712.
  • 9小野宪昭,门田晃一,津川昌也,等.Robbinsdeviceな用Lいた大肠菌バイオフイルムの解析[J].日本化学疗法学会杂志,1995,43:987.
  • 10Patel SS,Balfoud JA,Brysnn HM. Fosfnmyein tromethamine are view of its antibacterial activity,pharmaeokinetie properties and therapeutic efficacy as a single dose oral Ireatment for acute uncomplicated lower urinary tract infections [J]. Drugs, 1997,53(4) :637.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部